Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James T Willerson

Circulation

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Circulation|June 3, 2004
Inflammation as a cardiovascular risk factorJames T Willerson, Paul M Ridker
Circulation|October 8, 2003
Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cellsPaolo Calabró, James T Willerson, Edward T H Yeh
Circulation|November 20, 2002
E2F-1 regulates nuclear factor-kappaB activity and cell adhesion: potential antiinflammatory activity of the transcription factor E2F-1Min Chen, Carrie Capps, James T Willerson, et al.
Circulation|November 17, 2004
Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathwaysPaolo Calabro, Ismael Samudio, James T Willerson, et al.
Circulation|March 26, 2003
Superparamagnetic iron oxide-based method for quantifying recruitment of monocytes to mouse atherosclerotic lesions in vivo: enhancement by tissue necrosis factor-alpha, interleukin-1beta, and interferon-gammaSilvio Litovsky, Mohammad Madjid, Alireza Zarrabi, et al.
Circulation|June 11, 2003
Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trialEugene S Chung, Milton Packer, Kim Hung Lo, et al.
Circulation|December 15, 2004
Both cell fusion and transdifferentiation account for the transformation of human peripheral blood CD34-positive cells into cardiomyocytes in vivoSui Zhang, Dachun Wang, Zeev Estrov, et al.
Circulation|October 22, 2003
Transdifferentiation of human peripheral blood CD34+-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivoEdward T H Yeh, Sui Zhang, Henry D Wu, et al.
Circulation|July 12, 2013
Endothelial-like progenitor cells engineered to produce prostacyclin rescue monocrotaline-induced pulmonary arterial hypertension and provide right ventricle benefitsLei Zhou, Zhiqiang Chen, Peter Vanderslice, et al.
Circulation|April 13, 2005
Local gene transduction of cyclooxygenase-1 increases blood flow in injured atherosclerotic rabbit arteriesQi Liu, Zhi-Qiang Chen, George C Bobustuc, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Circulation|June 3, 2004
Inflammation as a cardiovascular risk factorJames T Willerson, Paul M Ridker
Circulation|October 8, 2003
Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cellsPaolo Calabró, James T Willerson, Edward T H Yeh
Circulation|November 20, 2002
E2F-1 regulates nuclear factor-kappaB activity and cell adhesion: potential antiinflammatory activity of the transcription factor E2F-1Min Chen, Carrie Capps, James T Willerson, et al.
Circulation|November 17, 2004
Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathwaysPaolo Calabro, Ismael Samudio, James T Willerson, et al.
Circulation|March 26, 2003
Superparamagnetic iron oxide-based method for quantifying recruitment of monocytes to mouse atherosclerotic lesions in vivo: enhancement by tissue necrosis factor-alpha, interleukin-1beta, and interferon-gammaSilvio Litovsky, Mohammad Madjid, Alireza Zarrabi, et al.
Circulation|June 11, 2003
Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trialEugene S Chung, Milton Packer, Kim Hung Lo, et al.
Circulation|December 15, 2004
Both cell fusion and transdifferentiation account for the transformation of human peripheral blood CD34-positive cells into cardiomyocytes in vivoSui Zhang, Dachun Wang, Zeev Estrov, et al.
Circulation|October 22, 2003
Transdifferentiation of human peripheral blood CD34+-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivoEdward T H Yeh, Sui Zhang, Henry D Wu, et al.
Circulation|July 12, 2013
Endothelial-like progenitor cells engineered to produce prostacyclin rescue monocrotaline-induced pulmonary arterial hypertension and provide right ventricle benefitsLei Zhou, Zhiqiang Chen, Peter Vanderslice, et al.
Circulation|April 13, 2005
Local gene transduction of cyclooxygenase-1 increases blood flow in injured atherosclerotic rabbit arteriesQi Liu, Zhi-Qiang Chen, George C Bobustuc, et al.
Pageof 3